Nouvelles approches thérapeutiques dans les leucémies aiguës myéloïdes ayant des mutations des gènes de la voie RAS

Justine Decroocq(Centre National de la Recherche Scientifique)

HAL (Le Centre pour la Communication Scientifique Directe)

September 10, 2019

Cited by 0

Related Papers

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

|Blood|2015|383

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia

|Haematologica|2021|181

Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

|Blood|2022|80

RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia

|Leukemia|2022|24